APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hepatitis B Vaccines

Hepatitis B vaccine is a vaccine that prevents hepatitis B.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hepatitis B vaccine is a vaccine that prevents hepatitis B.

Selected research

Market Structure

Global Hepatitis B Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173997940328 December 2025185 pages

Choose your research edition.

Industry ResearchHepatitis B Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepatitis B Vaccines Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Hepatitis B Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepatitis B Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepatitis B Vaccines Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Hepatitis B vaccine is a vaccine that prevents hepatitis B.

In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.

The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.

Read the full market overview

Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.

Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report provides an overview of the global Hepatitis B Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hepatitis B Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hepatitis B Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hepatitis B Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Hepatitis B Vaccines Segment by Company

GSK

NCPC

Merck

Bio Kangtai

Dynavax

Hissen

KM Biologics

LG Life Sciences

Serum Institute

Hepatitis B Vaccines Segment by Type

Yeast Derived

CHO Derived

Hepatitis B Vaccines Segment by Application

Children

Adult

Hepatitis B Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis B Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepatitis B Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis B Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hepatitis B Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hepatitis B Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hepatitis B Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hepatitis B Vaccines Industry Trends Table 2. Hepatitis B Vaccines Industry Drivers Table 3. Hepatitis B Vaccines Industry Opportunities and Challenges Table 4. Hepatitis B Vaccines Industry Restraints Table 5. Global Hepatitis B Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hepatitis B Vaccines Sales by Manufacturers (M Doses) & (2021-2026) Table 8. Global Hepatitis B Vaccines Sales Market Share by Manufacturers Table 9. Global Hepatitis B Vaccines Average Sales Price (USD/Doses) of Manufacturers (2021-2026) Table 10. Global Hepatitis B Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hepatitis B Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hepatitis B Vaccines Manufacturers, Product Type & Application Table 13. Global Hepatitis B Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hepatitis B Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Yeast Derived Table 17. Major Manufacturers of CHO Derived Table 18. Global Hepatitis B Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 19. Global Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses) Table 20. Global Hepatitis B Vaccines Sales by Type (2027-2032) & (M Doses) Table 21. Global Hepatitis B Vaccines Sales Market Share by Type (2021-2026) Table 22. Global Hepatitis B Vaccines Sales Market Share by Type (2027-2032) Table 23. Global Hepatitis B Vaccines Revenue by Type 2021 VS 2025 VS 2032 (M Doses) Table 24. Global Hepatitis B Vaccines Revenue by Type (2021-2026) & (M Doses) Table 25. Global Hepatitis B Vaccines Revenue by Type (2027-2032) & (M Doses) Table 26. Global Hepatitis B Vaccines Revenue Market Share by Type (2021-2026) Table 27. Global Hepatitis B Vaccines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Children Table 29. Major Manufacturers of Adult Table 30. Global Hepatitis B Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 31. Global Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses) Table 32. Global Hepatitis B Vaccines Sales by Application (2027-2032) & (M Doses) Table 33. Global Hepatitis B Vaccines Sales Market Share by Application (2021-2026) Table 34. Global Hepatitis B Vaccines Sales Market Share by Application (2027-2032) Table 35. Global Hepatitis B Vaccines Revenue by Application 2021 VS 2025 VS 2032 (M Doses) Table 36. Global Hepatitis B Vaccines Revenue by Application (2021-2026) & (M Doses) Table 37. Global Hepatitis B Vaccines Revenue by Application (2027-2032) & (M Doses) Table 38. Global Hepatitis B Vaccines Revenue Market Share by Application (2021-2026) Table 39. Global Hepatitis B Vaccines Revenue Market Share by Application (2027-2032) Table 40. Global Hepatitis B Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 41. Global Hepatitis B Vaccines Sales by Region (2021-2026) & (M Doses) Table 42. Global Hepatitis B Vaccines Sales Market Share by Region (2021-2026) Table 43. Global Hepatitis B Vaccines Sales Forecasted by Region (2027-2032) & (M Doses) Table 44. Global Hepatitis B Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Hepatitis B Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 46. North America Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses) Table 47. North America Hepatitis B Vaccines Sales by Country (2027-2032) & (M Doses) Table 48. Europe Hepatitis B Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 49. Europe Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses) Table 50. Europe Hepatitis B Vaccines Sales by Country (2027-2032) & (M Doses) Table 51. Asia Pacific Hepatitis B Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 52. Asia Pacific Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses) Table 53. Asia Pacific Hepatitis B Vaccines Sales by Country (2027-2032) & (M Doses) Table 54. South America, Middle East and Africa Hepatitis B Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 55. South America, Middle East and Africa Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses) Table 56. South America, Middle East and Africa Hepatitis B Vaccines Sales by Country (2027-2032) & (M Doses) Table 57. Global Hepatitis B Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Hepatitis B Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Hepatitis B Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Hepatitis B Vaccines Revenue Market Share by Region (2021-2026) Table 61. Global Hepatitis B Vaccines Revenue Market Share by Region (2027-2032) Table 62. GSK Company Information Table 63. GSK Business Overview Table 64. GSK Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. GSK Hepatitis B Vaccines Product Portfolio Table 66. GSK Recent Development Table 67. NCPC Company Information Table 68. NCPC Business Overview Table 69. NCPC Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. NCPC Hepatitis B Vaccines Product Portfolio Table 71. NCPC Recent Development Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Merck Hepatitis B Vaccines Product Portfolio Table 76. Merck Recent Development Table 77. Bio Kangtai Company Information Table 78. Bio Kangtai Business Overview Table 79. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Bio Kangtai Hepatitis B Vaccines Product Portfolio Table 81. Bio Kangtai Recent Development Table 82. Dynavax Company Information Table 83. Dynavax Business Overview Table 84. Dynavax Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Dynavax Hepatitis B Vaccines Product Portfolio Table 86. Dynavax Recent Development Table 87. Hissen Company Information Table 88. Hissen Business Overview Table 89. Hissen Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Hissen Hepatitis B Vaccines Product Portfolio Table 91. Hissen Recent Development Table 92. KM Biologics Company Information Table 93. KM Biologics Business Overview Table 94. KM Biologics Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. KM Biologics Hepatitis B Vaccines Product Portfolio Table 96. KM Biologics Recent Development Table 97. LG Life Sciences Company Information Table 98. LG Life Sciences Business Overview Table 99. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. LG Life Sciences Hepatitis B Vaccines Product Portfolio Table 101. LG Life Sciences Recent Development Table 102. Serum Institute Company Information Table 103. Serum Institute Business Overview Table 104. Serum Institute Hepatitis B Vaccines Sales (M Doses), Price (USD/Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Serum Institute Hepatitis B Vaccines Product Portfolio Table 106. Serum Institute Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Hepatitis B Vaccines Distributors List Table 110. Hepatitis B Vaccines Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Hepatitis B Vaccines Product Image Figure 2. Global Hepatitis B Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepatitis B Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Hepatitis B Vaccines Sales (2021-2032) & (M Doses) Figure 5. Global Hepatitis B Vaccines Average Price (USD/Doses) & (2021-2032) Figure 6. Global Top 5 and 10 Hepatitis B Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Yeast Derived Image Figure 9. CHO Derived Image Figure 10. Global Hepatitis B Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 11. Global Hepatitis B Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hepatitis B Vaccines Sales Market Share by Type (2021-2032) Figure 13. Global Hepatitis B Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 14. Global Hepatitis B Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hepatitis B Vaccines Revenue Market Share by Type (2021-2032) Figure 16. Children Image Figure 17. Adult Image Figure 18. Global Hepatitis B Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 19. Global Hepatitis B Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Hepatitis B Vaccines Sales Market Share by Application (2021-2032) Figure 21. Global Hepatitis B Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 22. Global Hepatitis B Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Hepatitis B Vaccines Revenue Market Share by Application (2021-2032) Figure 24. North America Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 25. North America Hepatitis B Vaccines Sales Market Share by Country (2021-2032) Figure 26. U.S. Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 27. Canada Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 28. Mexico Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 29. Europe Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 30. Europe Hepatitis B Vaccines Sales Market Share by Country (2021-2032) Figure 31. Germany Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 32. France Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 33. U.K. Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 34. Italy Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 35. Netherlands Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 36. Asia Pacific Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 37. Asia Pacific Hepatitis B Vaccines Sales Market Share by Country (2021-2032) Figure 38. China Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 39. Japan Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 40. South Korea Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 41. Southeast Asia Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 42. India Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 43. Australia Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 44. South America, Middle East and Africa Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 45. South America, Middle East and Africa Hepatitis B Vaccines Sales Market Share by Country (2021-2032) Figure 46. Brazil Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 47. South Africa Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 48. Saudi Arabia Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 49. Turkey Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 50. Argentina Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 51. UAE Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 52. Egypt Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 53. Chile Hepatitis B Vaccines Sales and Growth Rate (2021-2032) & (M Doses) Figure 54. Global Hepatitis B Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Hepatitis B Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Figure 57. North America Hepatitis B Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Figure 59. Europe Hepatitis B Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Hepatitis B Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Hepatitis B Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Hepatitis B Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Hepatitis B Vaccines Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Hepatitis B Vaccines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Yeast Derived
  • CHO Derived
Applications
  • Children
  • Adult
Companies covered
  • GSK
  • NCPC
  • Merck
  • Bio Kangtai
  • Dynavax
  • Hissen
  • KM Biologics
  • LG Life Sciences
  • Serum Institute

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hepatitis B Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hepatitis B Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hepatitis B Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hepatitis B Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hepatitis B Vaccines Market Dynamics
  1. 2.1 Hepatitis B Vaccines Industry Trends
  2. 2.2 Hepatitis B Vaccines Industry Drivers
  3. 2.3 Hepatitis B Vaccines Industry Opportunities and Challenges
  4. 2.4 Hepatitis B Vaccines Industry Restraints
3 Hepatitis B Vaccines Market by Manufacturers
  1. 3.1 Global Hepatitis B Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hepatitis B Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hepatitis B Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hepatitis B Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hepatitis B Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hepatitis B Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Hepatitis B Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hepatitis B Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hepatitis B Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hepatitis B Vaccines Tier 1, Tier 2, and Tier 3
4 Hepatitis B Vaccines Market by Type
  1. 4.1 Hepatitis B Vaccines Type Introduction
  2. 4.1.1 Yeast Derived
  3. 4.1.2 CHO Derived
  4. 4.2 Global Hepatitis B Vaccines Sales by Type
  5. 4.2.1 Global Hepatitis B Vaccines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hepatitis B Vaccines Sales by Type (2021-2032)
  7. 4.2.3 Global Hepatitis B Vaccines Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hepatitis B Vaccines Revenue by Type
  9. 4.3.1 Global Hepatitis B Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hepatitis B Vaccines Revenue by Type (2021-2032)
  11. 4.3.3 Global Hepatitis B Vaccines Revenue Market Share by Type (2021-2032)
5 Hepatitis B Vaccines Market by Application
  1. 5.1 Hepatitis B Vaccines Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global Hepatitis B Vaccines Sales by Application
  5. 5.2.1 Global Hepatitis B Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hepatitis B Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Hepatitis B Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Hepatitis B Vaccines Revenue by Application
  9. 5.3.1 Global Hepatitis B Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hepatitis B Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Hepatitis B Vaccines Revenue Market Share by Application (2021-2032)
6 Global Hepatitis B Vaccines Sales by Region
  1. 6.1 Global Hepatitis B Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hepatitis B Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Hepatitis B Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Hepatitis B Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hepatitis B Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hepatitis B Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hepatitis B Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hepatitis B Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hepatitis B Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hepatitis B Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hepatitis B Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hepatitis B Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hepatitis B Vaccines Revenue by Region
  1. 7.1 Global Hepatitis B Vaccines Revenue by Region
  2. 7.1.1 Global Hepatitis B Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hepatitis B Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Hepatitis B Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Hepatitis B Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hepatitis B Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Hepatitis B Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hepatitis B Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Hepatitis B Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hepatitis B Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hepatitis B Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hepatitis B Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hepatitis B Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Hepatitis B Vaccines Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 NCPC
  8. 8.2.1 NCPC Company Information
  9. 8.2.2 NCPC Business Overview
  10. 8.2.3 NCPC Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 NCPC Hepatitis B Vaccines Product Portfolio
  12. 8.2.5 NCPC Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Hepatitis B Vaccines Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Bio Kangtai
  20. 8.4.1 Bio Kangtai Company Information
  21. 8.4.2 Bio Kangtai Business Overview
  22. 8.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bio Kangtai Hepatitis B Vaccines Product Portfolio
  24. 8.4.5 Bio Kangtai Recent Developments
  25. 8.5 Dynavax
  26. 8.5.1 Dynavax Company Information
  27. 8.5.2 Dynavax Business Overview
  28. 8.5.3 Dynavax Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dynavax Hepatitis B Vaccines Product Portfolio
  30. 8.5.5 Dynavax Recent Developments
  31. 8.6 Hissen
  32. 8.6.1 Hissen Company Information
  33. 8.6.2 Hissen Business Overview
  34. 8.6.3 Hissen Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hissen Hepatitis B Vaccines Product Portfolio
  36. 8.6.5 Hissen Recent Developments
  37. 8.7 KM Biologics
  38. 8.7.1 KM Biologics Company Information
  39. 8.7.2 KM Biologics Business Overview
  40. 8.7.3 KM Biologics Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 KM Biologics Hepatitis B Vaccines Product Portfolio
  42. 8.7.5 KM Biologics Recent Developments
  43. 8.8 LG Life Sciences
  44. 8.8.1 LG Life Sciences Company Information
  45. 8.8.2 LG Life Sciences Business Overview
  46. 8.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 LG Life Sciences Hepatitis B Vaccines Product Portfolio
  48. 8.8.5 LG Life Sciences Recent Developments
  49. 8.9 Serum Institute
  50. 8.9.1 Serum Institute Company Information
  51. 8.9.2 Serum Institute Business Overview
  52. 8.9.3 Serum Institute Hepatitis B Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Serum Institute Hepatitis B Vaccines Product Portfolio
  54. 8.9.5 Serum Institute Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hepatitis B Vaccines Value Chain Analysis
  2. 9.1.1 Hepatitis B Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hepatitis B Vaccines Production Mode & Process
  6. 9.2 Hepatitis B Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hepatitis B Vaccines Distributors
  9. 9.2.3 Hepatitis B Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst